BUY Divi's Laboratories Limited — Manas Jaiswal
byManas JaiswalHorizon: NA (inferred Swing (≤2wk))23 Sept 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·24 Sept · 5d ago
1 advisor has an active short-term BUY call on this stock
Advisor consensus · adjacent horizon·26 Aug · 1mo ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Divi's Laboratories
- BUY — Chandan Taparia, Motilal Oswal13 Nov 2026 · ~2 weeks · target ₹12,400 · Active
- BUY — Nuvama Wealth9 Nov 2026 · ~1 year · target ₹12,000 · Active
- BUY — Jefferies India9 Nov 2026 · ~1 year · target ₹12,550 · Active
- BUY — Morgan Stanley9 Nov 2026 · ~1 year · target ₹11,359 · Target hit
- SELL — Elara Capital9 Nov 2026 · ~1 year · target ₹6,539 · Active
More from Manas Jaiswal
- BUY LIC Housing Finance13 Nov 2026 · ~2 weeks · target ₹630 · Active
- BUY Indus Towers13 Nov 2026 · ~2 weeks · target ₹415 · Active
- BUY Angel One13 Nov 2026 · ~2 weeks · target ₹365 · Active
- BUY Multi Commodity Exchange of India13 Nov 2026 · ~2 weeks · target ₹3,950 · Active
- BUY Sun Pharmaceutical Industries13 Nov 2026 · Same day · target ₹1,950 · SL hit

